Bristol-Myers, Pfizer Again Sued Over Eliquis Risks

Law360, New York (July 7, 2017, 5:44 PM EDT) -- The daughter and partner of a man who died after taking the anticoagulant Eliquis on Wednesday accused the drug’s makers, Bristol-Myers Squibb Co. and Pfizer Inc., in New York state court of skimping on pre-approval testing and not coming forward about the drug’s risks.

The drugmakers conducted their trials in China, using “incompetent and untrustworthy agents” to cut costs, and have continued to place profits over safety, the suit alleges. Among those issues, the company has not advertised that there’s no way to reverse the drug when it goes awry, the complaint states.

“These representations were made by defendants with the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!